During the past decade, University of Texas, Memorial Hermann conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Texas, Memorial Hermann" #1 sponsor was "Edwards Lifesciences" with 2 trials, followed by "Baylor College of Medicine" with 1 trials sponsored, "ImmunoGen, Inc." with 1 trials sponsored, "Mallinckrodt" with 1 trials sponsored and "V-Wave Ltd" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas, Memorial Hermann" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas, Memorial Hermann" are "Aortic Stenosis, Severe" (1 trials), "Aortic Valve Stenosis" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "University of Texas, Memorial Hermann" in a lesser frequency.

Most popular intervention types in "University of Texas, Memorial Hermann" are "Device" (3 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Atorvastatin" (1 trials), "Control" (1 trials), "Mirvetuximab Soravtansine" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas, Memorial Hermann" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Texas, Memorial Hermann". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Texas, Memorial Hermann, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas, Memorial Hermann, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".